These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26878555)

  • 1. The use of human neurons for novel drug discovery in dementia research.
    Vargas-Caballero M; Willaime-Morawek S; Gomez-Nicola D; Perry VH; Bulters D; Mudher A
    Expert Opin Drug Discov; 2016; 11(4):355-67. PubMed ID: 26878555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
    Engle SJ; Blaha L; Kleiman RJ
    Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 5. 3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases.
    Korhonen P; Malm T; White AR
    Neurochem Int; 2018 Nov; 120():191-199. PubMed ID: 30176269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery.
    Chen SD; Li HQ; Cui M; Dong Q; Yu JT
    Expert Opin Drug Discov; 2020 Sep; 15(9):1081-1094. PubMed ID: 32425128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.
    Poon A; Zhang Y; Chandrasekaran A; Phanthong P; Schmid B; Nielsen TT; Freude KK
    N Biotechnol; 2017 Oct; 39(Pt B):190-198. PubMed ID: 28579476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on neurodegenerative diseases using induced pluripotent stem cells.
    Imamura K; Inoue H
    Psychogeriatrics; 2012 Jun; 12(2):115-9. PubMed ID: 22712645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.
    Wang C; Ward ME; Chen R; Liu K; Tracy TE; Chen X; Xie M; Sohn PD; Ludwig C; Meyer-Franke A; Karch CM; Ding S; Gan L
    Stem Cell Reports; 2017 Oct; 9(4):1221-1233. PubMed ID: 28966121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-Induced Pluripotent Stem Cell-Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases.
    Kiris E
    Adv Exp Med Biol; 2022; 1387():57-88. PubMed ID: 34921676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
    Cao L; Tan L; Jiang T; Zhu XC; Yu JT
    Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
    Haenseler W; Rajendran L
    Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging in a Dish: iPSC-Derived and Directly Induced Neurons for Studying Brain Aging and Age-Related Neurodegenerative Diseases.
    Mertens J; Reid D; Lau S; Kim Y; Gage FH
    Annu Rev Genet; 2018 Nov; 52():271-293. PubMed ID: 30208291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine.
    Silva MC; Haggarty SJ
    Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review.
    Saito-Diaz K; Zeltner N
    Clin Auton Res; 2019 Aug; 29(4):367-384. PubMed ID: 30631982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of established human iPSC-derived neurons to model neurodegenerative diseases.
    Meneghello G; Verheyen A; Van Ingen M; Kuijlaars J; Tuefferd M; Van Den Wyngaert I; Nuydens R
    Neuroscience; 2015 Aug; 301():204-12. PubMed ID: 26047731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.